Peter Friedli, Chairman
Peter Friedli has been a founder and principal of various venture investment firms since 1986. Mr. Friedli has over 31 years of entrepreneurial experience as an independent investment manager in venture capital and has specialized in investments predominantly domiciled in the United States in the areas of biotechnology and technology. He has held interests in more than 170 venture companies ranging from start-up to public companies. Peter Friedli possesses an active involvement in the management of a number of those companies and also serves on the board of them. Prior to that, he worked in the field of international management consulting for service and industrial companies in Europe and the United States.
Peter Friedli is a director of the portfolio company Osiris Therapeutics, Inc. Further, Mr. Friedli is President of Madison Investment Advisory, Inc.
Mr. Friedli is a founder of New Venturetec and has been a member of the Board of Directors since 1997.
Andreas von Sprecher, member and Secretary, Swiss
Andreas von Sprecher is a founding partner at the law firm Hüppi & von Sprecher. Prior to that Mr. von Sprecher worked as an attorney of law. He is involved in some entrepreneurial projects in the area of tourism and viniculture. Mr. von Sprecher graduated in Law at the University of Zurich and has been admitted to the bar of the Canton of Zurich in 1989. Mr. von Sprecher is Partner at Hüppi & von Sprecher. He is a member of the Board of Directors of SHV Interholding AG.
Mr. von Sprecher has been a member of the Board of Directors since 2002.
Michael Endres, Member, Swiss
Michael Endres is a senior partner at the law firm HütteLAW AG since 2005. Prior to that Mr. Endres worked as an attorney of law in different law firms in Zurich and Zug. Mr. Endres acts also as a civil law notary. Mr. Endres graduated in Law at the University of St. Gallen and has been admitted to the bar of the Canton of Zug in 2001.
Mr. Endres joined the Board of Directors in 2017.